8-K
MEDICINES CO /DE filed this form 8-K on 9 Aug 2017
- velhartice.info



Item 2.02. Results of Operations and Financial Condition.
On August 9, 2017 The Medicines Company (the “Company”) announced financial results for the three and six months ended June 30, 2017. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits
(d)    Exhibits

The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed:

99.1
Press release dated August 9, 2017 entitled “The Medicines Company Reports Second-Quarter 2017 Business and Financial Results”